THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2022 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
THRD
Shares outstanding
45,072,086
Price per share
$5.38
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
499,952
Total reported value
$1,192,160
% of total 13F portfolios
0%
Share change
-38,130,815
Value change
-$208,406,319
Number of holders
12
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BML Investment Partners, L.P. 8.2% $13,555,968 3,724,167 BML Investment Partners, L.P. 11 Feb 2025
FMR LLC 0% -93% $3,880 -$9,229,125 1,066 -100% FMR LLC 31 Mar 2025

As of 30 Sep 2025, 12 institutional investors reported holding 499,952 shares of THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD). This represents 1.1% of the company’s total 45,072,086 outstanding shares.

Institutional Holders of THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 458 $2,464 $5.38 1
2025 Q3 499,952 $1,192,160 -$208,406,319 $5.38 12
2025 Q2 38,704,293 $210,166,987 +$8,536,461 $5.43 103
2025 Q1 38,729,939 $134,393,181 -$121,107,857 $3.47 96
2024 Q4 44,947,123 $462,509,454 -$20,519,606 $10.29 92
2024 Q3 44,027,892 $596,562,722 +$50,979,988 $13.55 84
2024 Q2 40,245,021 $523,185,590 +$31,240,283 $13.00 75
2024 Q1 37,879,003 $357,578,025 -$3,097,288 $9.44 69
2023 Q4 37,920,058 $415,983,988 +$11,326,573 $10.97 60
2023 Q3 37,791,218 $241,485,928 +$16,508,500 $6.39 54
2023 Q2 36,060,997 $173,452,378 -$700,007 $4.81 46
2023 Q1 36,345,333 $149,741,793 +$2,662,526 $4.12 48
2022 Q4 35,616,929 $153,146,309 -$14,981,924 $4.30 50
2022 Q3 35,467,923 $672,825,931 +$672,826,165 $18.97 40